67.00
Schlusskurs vom Vortag:
$65.54
Offen:
$65.51
24-Stunden-Volumen:
31,146
Relative Volume:
0.28
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.64%
1M Leistung:
+2.95%
6M Leistung:
+1.96%
1J Leistung:
+0.77%
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IHE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IHE
Ishares U S Pharmaceuticals Etf
|
67.00 | 0 | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
303.90 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
617.13 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
620.07 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
240.66 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
545.96 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
IHE: Healthcare Dashboard For June (NYSEARCA:IHE) - Seeking Alpha
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Wealth Enhancement Advisory Services LLC Acquires 1,065 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Wealthcare Advisory Partners LLC Sells 481 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Yousif Capital Management LLC Sells 577 Shares of Darden Restaurants, Inc. (NYSE:DRI) - Defense World
NBC Securities Inc. Takes $30,000 Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Millennium Management LLC Takes Position in iShares Core MSCI EAFE ETF (BATS:IEFA) - Defense World
Bank of America Corp DE Cuts Position in Resources Connection, Inc. (NASDAQ:RGP) - Defense World
Bank of America Corp DE Purchases New Holdings in ServiceTitan Inc. (NASDAQ:TTAN) - Defense World
Bank of America Corp DE Boosts Holdings in Kura Sushi USA, Inc. (NASDAQ:KRUS) - Defense World
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading - Benzinga
Ameriprise Financial Inc. Makes New $260,000 Investment in Five Star Bancorp (NASDAQ:FSBC) - Defense World
Bank of America Corp DE Cuts Stock Holdings in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World
Ameriprise Financial Inc. Boosts Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Squarepoint Ops LLC Invests $334,000 in United States Lime & Minerals, Inc. (NASDAQ:USLM) - Defense World
CoStar Group (NASDAQ:CSGP) Coverage Initiated by Analysts at Bank of America - Defense World
BioLineRx (NASDAQ:BLRX) Given “Buy” Rating at HC Wainwright - Defense World
D. E. Shaw & Co. Inc. Takes $397,000 Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Purchased by Citadel Advisors LLC - Defense World
Hormel Foods’ (HRL) Equal Weight Rating Reiterated at Stephens - Defense World
Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Trump Sparks New Chapter In Transatlantic Trade War: What The US Buys From Europe - Benzinga
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - sharewise
Captrust Financial Advisors Acquires 171 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Ameriprise Financial Inc. Boosts Stake in Hillenbrand, Inc. (NYSE:HI) - Defense World
Atlantic American (NASDAQ:AAME) Coverage Initiated at StockNews.com - Defense World
StockNews.com Upgrades North American Construction Group (NYSE:NOA) to “Hold” - Defense World
Vodafone Group Public Limited (NASDAQ:VOD) Receives Consensus Rating of “Hold” from Brokerages - Defense World
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Comerica Bank Raises Stock Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Comerica Bank Sells 2,587 Shares of iShares MSCI ACWI Low Carbon Target ETF (NYSEARCA:CRBN) - Defense World
Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking - Seeking Alpha
Biotech Stocks Surge 3.3% Despite Trump’s Drug Price Cut Pledge: $IBB and $IHE Performance Analysis - Blockchain News
US stocks soar as Dow jumps 1,100 points on tariff truce between US and China - Invezz
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Stifel Financial Corp Makes New Investment in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Tower Research Capital LLC TRC Cuts Stake in iShares U.S. Energy ETF (NYSEARCA:IYE) - Defense World
Tower Research Capital LLC TRC Sells 17,351 Shares of iShares U.S. Telecommunications ETF (BATS:IYZ) - Defense World
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency' - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - NewsBreak: Local News & Alerts
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Do Wall Street Analysts Like Viatris Stock? - inkl
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Are Wall Street Analysts Bullish on Merck Stock? - inkl
Trump signs Executive Order to streamline domestic drug production (updated) - Seeking Alpha
Are Wall Street Analysts Bullish on Walgreens Boots Stock? - inkl
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Unusually-High Trading Volume – What’s Next? - Defense World
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Sold by Envestnet Asset Management Inc. - Defense World
Are Wall Street Analysts Bullish on Bristol-Myers Stock? - inkl
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):